T regulatory cell separation for clinical application

Transfusion and Apheresis Science

Volumn 47, Issue 2, 2012, Pages 213-216

  Di Ianni, Mauro ^a,b   Del Papa, Beatrice ^a   Zei, Tiziana ^a   Iacucci Ostini, Roberta ^a   Cecchini, Debora ^a   Cantelmi, Maria Grazia ^a   Baldoni, Stefano ^a   Sportoletti, Paolo ^a   Cavalli, Laura ^a   Carotti, Alessandra ^a   Pierini, Antonio ^a   Falini, Brunangelo ^a   Martelli, Massimo F ^a   Falzetti, Franca ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CD19 ANTIBODY; OKT 8; TRANSCRIPTION FACTOR FOXP3;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ CD25+ T LYMPHOCYTE; CELL FRACTIONATION; CELL ISOLATION; CELL SEPARATION; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNITY; IMMUNOPHENOTYPING; LEUKAPHERESIS; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; CELL SEPARATION; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOPHENOTYPING; LEUKAPHERESIS; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 84865404558     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2012.06.007     Document Type: Review

References (27)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Ann Rev Immunol 2004, 22:531-562.
2. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining self-tolerance. J Immunol 1999, 162:5317-5326.
3. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001, 31:1247-1254.
4. +CD25 high regulatory cells in human peripheral blood. J Immunol 2001, 167:1245-1253.
5. Hoffmann P., Ermann J., Edinger M., Fathman C.G., Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002, 196:389-399.
6. Cohen J.L., Trenado A., Vasey D., Klatzmann D., Salomon B.L. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002, 196:401-406.
7. Taylor P.A., Lees C.J. Blazar BR The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002, 99:3493-3499.
8. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003, 9:1144-1150.
9. + regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 2003, 112:1688-1696.
10. Jones S.C., Murphy G.F., Korngold R. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant 2003, 9:243-256.
11. Nguyen V.H., Shashidhar S., Chanq D.S., Ho L., Kambham N., Bachmann M., et al. The impact of regulatory T cells on T cell immunity following hematopoeitic cell transplantation. Blood 2008, 111:945-953.
12. Fontenot J.D., Rasmussen J.P., Willliams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor FoxP3. Immunity 2005, 22:329-341.
13. Williams L.M., Rudensky A. Maintenance of the FoxP3-dependent developmental program in mature regulatory T cells requires continued expression of FoxP3. Nature Immunol 2007, 8:277-284.
14. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., et al. Single-cell analysis of normal and FoxP3-mutant human T cells: FoxP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006, 103:6659-6664.
15. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 2005, 6:1219-1227.
16. Seddiki N., Santner-Nanan B., Martinson J., Zaunders J., Sasson S., Landay A., et al. Expression of interleukin (IL)-2 and Il-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006, 7:1693-1700.
17. + T reg cells. J Exp Med 2006, 203:1701-1711.
18. + natural T regulatory lymphocytes for clinical applications. Clin Exp Immunol 2009, 156:246-253.
19. Di Ianni M., Falzetti F., Carotti A., Terenzi A., Castellino F., Bonifacio E., et al. Tregs prevent GvHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011, 117:3921-3928.
20. Brunstein C.G., Miller J.S., Cao Q., McKenna D.H., Hippen K.L., Curtsinger J., et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. Blood 2011, 117:1061-1070.
21. Weinstock D.M., Ambrossi G.G., Brennan C., Kiehn T.E., Jakubowski A. Preemptive diagnosis and treatment of Epstein-Barr virus associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: an approach in development. Bone Marrow Transplant 2006, 37:539-546.
22. Di Ianni M., Del Papa B., De Ioanni M., Moretti L., Bonifacio E., Cecchini D., et al. Mesenchymal cells recruit and regulate T regulatory cells. Exp Hematol 2008, 36:309-318.
23. high T cells gives rise to homogeneous regulatory T cell lines upon in vitro expansion. Blood 2006, 108:4260-4267.
24. + T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
25. + regulatory T cell in the human immune system. Nat Rev Immunol 2010, 10:490-500.
26. + Treg free of contaminating effector cells. Blood 2009, 113:827-836.
27. Di Ianni M., Falzetti F., Carotti A., Terenzi A., Ruggeri L., Pierini A., de Fazio V., Zoi V., Massei M.S., Reisner Y., Velardi A., Aversa F., Martelli M.F. Adoptive immunotherapy with Tregs and Tcons ensures low TRM and a low incidence of post transplant leukaemia relapse after HLA haploidentical transplants for acute leukaemia. Blood (ASH Annual Meeting Abstracts) 2011, 118:154.